** Shares of animal diagnostics maker IDEXX Laboratories
IDXX.O rise 8.5% to $458 premarket
** IDXX posts Q4 rev. of $954.3 mln, above analysts' est. of
$935 mln, according to data compiled by LSEG, driven by strong
demand for its veterinary diagnostic services despite persistent
weakness in visits to the vet clinic
** IDXX posts Q4 adj. EPS of $2.62/shr, above analysts' est.
of $2.40/shr - LSEG
** IDXX forecasts 2025 rev. between $4.06 bln and $4.17 bln,
the midpoint of which is slightly below analysts' estimates of
$4.14 bln
** IDXX forecasts 2025 EPS to be between $11.74 and $12.24
per share vs. analysts' est. of $11.92 per share
** IDXXn fell ~25% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))